Kim, Miso, Jeong-Ok Lee, Jiwon Koh, Tae Min Kim, Ji Yun Lee, Yoon Kyung Jeon, Bhumsuk Keam, Dong-Wan Kim, Jong Seok Lee, and Dae Seog Heo. 2021. “A Phase II Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Epstein-Barr Virus-Positive and CD30-Positive Lymphomas”. Haematologica 106 (8). Pavia, Italy, 2277-80. https://doi.org/10.3324/haematol.2021.278301.